Balodis IM, Potenza MN. The Biology and Treatment of Gambling Disorder. In: Johnson BA. Addiction Medicine: Science and Practice. 2nd ed. Elsevier; 2020.
Blank L, Baxter S, Woods HB, Goyder E. Should screening for risk of gambling-related harm be undertaken in health, care and support settings? A systematic review of the international evidence. Addict Sci Clin Pract 2021;16(1):35. https://www.ncbi.nlm.nih.gov/pubmed/34051852
Browne B. Gambling on games: how video games expose children to gambling. Centre for Responsible Technology; 2020. https://apo.org.au/node/274961
Cowlishaw S, Merkouris S, Dowling N, Anderson C, Jackson A, Thomas S. Psychological therapies for pathological and problem gambling. Cochrane Database Syst Rev 2012;11:CD008937. https://www.ncbi.nlm.nih.gov/pubmed/23152266
Dowling N. The impact of gambling problems on families (AGRC Discussion Paper No. 1). Melbourne: Australian Gambling Research Centre (AGRC); 2014. https://aifs.gov.au/agrc/publications
Dowling NA, Merkouris SS, Dias S, Rodda SN, Manning V, Youssef GJ, et al. The diagnostic accuracy of brief screening instruments for problem gambling: A systematic review and meta-analysis. Clin Psychol Rev 2019;74:101784. https://www.ncbi.nlm.nih.gov/pubmed/31759246
Kovanen L, Basnet S, Castren S, Pankakoski M, Saarikoski ST, Partonen T, et al. A Randomised, Double-Blind, Placebo-Controlled Trial of As-Needed Naltrexone in the Treatment of Pathological Gambling. Eur Addict Res 2016;22(2):70-9. https://www.ncbi.nlm.nih.gov/pubmed/26339899
Ward S, Smith N, Bowden-Jones H. The use of naltrexone in pathological and problem gambling: A UK case series. J Behav Addict 2018;7(3):827-33. https://www.ncbi.nlm.nih.gov/pubmed/30238780
World Health Organization (WHO). International Classification of Diseases 11th Revision. WHO. Accessed February 2022. https://icd.who.int/en